UCP2 and Miyoshi myopathy: A potential mechanism of UCP2-caused chemoresistance is a reduction in the generation of ROS.While this mechanism has been proven for gemcitabine, doxorubicin and cisplatin [22], further studies are needed for agents used in the treatment of MM.